Form 4 for INSP Inspire Medical Systems, Inc.

Accepted 2023-01-27 00:00:00 ET · period of report 2023-01-25 · accession 0001104659-23-007634 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2023-01-27	2023-01-25	INSP	Buchholz Richard	CFO	M - OptEx	$25.57	+6,100	37.7K	+19%	+$156.0K
DM	2023-01-27	2023-01-25	INSP	Buchholz Richard	CFO	M - OptEx	$0.00	-6,100	7,159	-46%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-01-25	M	A	117	$71.00	37,794	D	—	—
2	Common	Common Stock	2023-01-25	M	A	2,693	$42.15	40,487	D	—	—
3	Common	Common Stock	2023-01-25	M	A	3,290	$10.38	37,677	D	—	—
4	Derivative	Employee Stock Option (Right to Buy)	2023-01-25	M	D	3,290	$0.00	0	D	$10.38 · — to 2028-04-09	3,290 Common Stock	(F1) The option is fully vested and exercisable.
5	Derivative	Employee Stock Option (Right to Buy)	2023-01-25	M	D	117	$0.00	17,849	D	$71.00 · — to 2029-12-16	117 Common Stock	(F2) The option vested and became exercisable as to 25% of the original 20,000 underlying shares on December 16, 2020 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
6	Derivative	Employee Stock Option (Right to Buy)	2023-01-25	M	D	2,693	$0.00	7,159	D	$42.15 · — to 2028-12-18	2,693 Common Stock	(F1) The option is fully vested and exercisable.